112
Participants
Start Date
December 17, 2018
Primary Completion Date
March 24, 2021
Study Completion Date
October 13, 2021
Orbital Circumferential Atherectomy
Remove atherosclerotic plaque and modify vessel wall compliance within peripheral arterial vessels. The therapy is intended for patients who are acceptable candidates for percutaneous transluminal atherectomy.
First Coast Cardiovascular Institute, Jacksonville
Cardiovascular Research of North Florida, LLC, Gainesville
Orlando Heart and Vascular Institute, Altamonte Springs
Palm Vascular Center of Broward, LLC, Fort Lauderdale
Cardiology Partners Clinical Research Institute, Palm Beach Gardens
Eastlake Cardiovascular, PC, Saint Clair Shores
Advanced Cardiac & Vascular Centers for Amputation Prevention, Grand Rapids
Cardiovascular Institute of the South, Houma
Cardiovascular Institute of the South, Opelousas
Cardiovascular Associates of East Texas, Tyler
Orion Medical Research, LLC, Pasadena
Cardiothoracic and Vascular Surgeons, Austin
Texas Tech University Medical Center, Lubbock
Lead Sponsor
Collaborators (1)
Libra Medical
OTHER
Cardio Flow, Inc.
INDUSTRY